# Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler

> **NCT01593644** · PHASE2 · UNKNOWN · sponsor: **Adenobio N.V** · enrollment: 75 (estimated)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DRUG:** adenosine + dipyridamole

## Key facts

- **NCT ID:** NCT01593644
- **Lead sponsor:** Adenobio N.V
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2013-03
- **Final completion:** —
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2012-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01593644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01593644, "Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01593644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*